Objective
Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical and clinical risk factors and linked to a state of chronic low grade inflammation. YKL-40 is known as an inflammatory glycoprotein which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS.
Methods
In this prospective cross-sectional study, a total 186 consecutive patients [n=122 MS present and n=64 MS absent] were enrolled. MS was defined according to NCEP-ATP III criteria. Serum YKL-40 and hs-CRP levels were measured for all participants. Independent predictors of MS were determined by logistic regression analysis.
Methods
In this prospective cross-sectional study, a total 186 consecutive patients [n=122 MS present and n=64 MS absent] were enrolled. MS was defined according to NCEP-ATP III criteria. Serum YKL-40 and hs-CRP levels were measured for all participants. Independent predictors of MS were determined by logistic regression analysis.
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)